Selected research
Industry Research
Cancer Imaging Software Industry Research Report 2026
Market perspective
The global Cancer Imaging Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cancer Imaging Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cancer Imaging Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cancer Imaging Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cancer Imaging Software include Imaris, Varian, DOSIsoft, Certis Oncology, MIM Software Inc., Arterys, SIEMENS, Brainomix and Oncology Systems Limited, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cancer Imaging Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cancer Imaging Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cancer Imaging Software Market by Company
Imaris
Varian
DOSIsoft
Certis Oncology
MIM Software Inc.
Arterys
SIEMENS
Brainomix
Oncology Systems Limited
Mirada
GE HealthCare
Mint Medical
Cancer Imaging Software Segment by Type
CT
MRI
MRA
Others
Cancer Imaging Software Segment by Application
Clinical Routine
Clinical Trials
Cancer Imaging Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Imaging Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cancer Imaging Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Imaging Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cancer Imaging Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- CT
- MRI
- MRA
- Others
Applications
- Clinical Routine
- Clinical Trials
Companies covered
- Imaris
- Varian
- DOSIsoft
- Certis Oncology
- MIM Software Inc.
- Arterys
- SIEMENS
- Brainomix
- Oncology Systems Limited
- Mirada
- GE HealthCare
- Mint Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cancer Imaging Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 CT
- 2.2.3 MRI
- 2.2.4 MRA
- 2.2.5 Others
- 2.3 Cancer Imaging Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical Routine
- 2.3.3 Clinical Trials
- 2.4 Assumptions and Limitations
3 Cancer Imaging Software Breakdown Data by Type
- 3.1 Global Cancer Imaging Software Historic Market Size by Type (2021-2026)
- 3.2 Global Cancer Imaging Software Forecasted Market Size by Type (2027-2032)
4 Cancer Imaging Software Breakdown Data by Application
- 4.1 Global Cancer Imaging Software Historic Market Size by Application (2021-2026)
- 4.2 Global Cancer Imaging Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cancer Imaging Software Market Perspective (2021-2032)
- 5.2 Global Cancer Imaging Software Growth Trends by Region
- 5.2.1 Global Cancer Imaging Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cancer Imaging Software Historic Market Size by Region (2021-2026)
- 5.2.3 Cancer Imaging Software Forecasted Market Size by Region (2027-2032)
- 5.3 Cancer Imaging Software Market Dynamics
- 5.3.1 Cancer Imaging Software Industry Trends
- 5.3.2 Cancer Imaging Software Market Drivers
- 5.3.3 Cancer Imaging Software Market Challenges
- 5.3.4 Cancer Imaging Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cancer Imaging Software Players by Revenue
- 6.1.1 Global Top Cancer Imaging Software Players by Revenue (2021-2026)
- 6.1.2 Global Cancer Imaging Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Cancer Imaging Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cancer Imaging Software Head Office and Area Served
- 6.4 Global Cancer Imaging Software Players, Product Type & Application
- 6.5 Global Cancer Imaging Software Manufacturers Established Date
- 6.6 Global Cancer Imaging Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cancer Imaging Software Market Size (2021-2032)
- 7.2 North America Cancer Imaging Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cancer Imaging Software Market Size by Country (2021-2026)
- 7.4 North America Cancer Imaging Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cancer Imaging Software Market Size (2021-2032)
- 8.2 Europe Cancer Imaging Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cancer Imaging Software Market Size by Country (2021-2026)
- 8.4 Europe Cancer Imaging Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cancer Imaging Software Market Size (2021-2032)
- 9.2 Asia-Pacific Cancer Imaging Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cancer Imaging Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cancer Imaging Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cancer Imaging Software Market Size (2021-2032)
- 10.2 South America Cancer Imaging Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cancer Imaging Software Market Size by Country (2021-2026)
- 10.4 South America Cancer Imaging Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cancer Imaging Software Market Size (2021-2032)
- 11.2 Middle East & Africa Cancer Imaging Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cancer Imaging Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cancer Imaging Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Imaris
- 12.1.1 Imaris Company Information
- 12.1.2 Imaris Business Overview
- 12.1.3 Imaris Revenue in Cancer Imaging Software Business (2021-2026)
- 12.1.4 Imaris Cancer Imaging Software Product Portfolio
- 12.1.5 Imaris Recent Developments
- 12.2 Varian
- 12.2.1 Varian Company Information
- 12.2.2 Varian Business Overview
- 12.2.3 Varian Revenue in Cancer Imaging Software Business (2021-2026)
- 12.2.4 Varian Cancer Imaging Software Product Portfolio
- 12.2.5 Varian Recent Developments
- 12.3 DOSIsoft
- 12.3.1 DOSIsoft Company Information
- 12.3.2 DOSIsoft Business Overview
- 12.3.3 DOSIsoft Revenue in Cancer Imaging Software Business (2021-2026)
- 12.3.4 DOSIsoft Cancer Imaging Software Product Portfolio
- 12.3.5 DOSIsoft Recent Developments
- 12.4 Certis Oncology
- 12.4.1 Certis Oncology Company Information
- 12.4.2 Certis Oncology Business Overview
- 12.4.3 Certis Oncology Revenue in Cancer Imaging Software Business (2021-2026)
- 12.4.4 Certis Oncology Cancer Imaging Software Product Portfolio
- 12.4.5 Certis Oncology Recent Developments
- 12.5 MIM Software Inc.
- 12.5.1 MIM Software Inc. Company Information
- 12.5.2 MIM Software Inc. Business Overview
- 12.5.3 MIM Software Inc. Revenue in Cancer Imaging Software Business (2021-2026)
- 12.5.4 MIM Software Inc. Cancer Imaging Software Product Portfolio
- 12.5.5 MIM Software Inc. Recent Developments
- 12.6 Arterys
- 12.6.1 Arterys Company Information
- 12.6.2 Arterys Business Overview
- 12.6.3 Arterys Revenue in Cancer Imaging Software Business (2021-2026)
- 12.6.4 Arterys Cancer Imaging Software Product Portfolio
- 12.6.5 Arterys Recent Developments
- 12.7 SIEMENS
- 12.7.1 SIEMENS Company Information
- 12.7.2 SIEMENS Business Overview
- 12.7.3 SIEMENS Revenue in Cancer Imaging Software Business (2021-2026)
- 12.7.4 SIEMENS Cancer Imaging Software Product Portfolio
- 12.7.5 SIEMENS Recent Developments
- 12.8 Brainomix
- 12.8.1 Brainomix Company Information
- 12.8.2 Brainomix Business Overview
- 12.8.3 Brainomix Revenue in Cancer Imaging Software Business (2021-2026)
- 12.8.4 Brainomix Cancer Imaging Software Product Portfolio
- 12.8.5 Brainomix Recent Developments
- 12.9 Oncology Systems Limited
- 12.9.1 Oncology Systems Limited Company Information
- 12.9.2 Oncology Systems Limited Business Overview
- 12.9.3 Oncology Systems Limited Revenue in Cancer Imaging Software Business (2021-2026)
- 12.9.4 Oncology Systems Limited Cancer Imaging Software Product Portfolio
- 12.9.5 Oncology Systems Limited Recent Developments
- 12.10 Mirada
- 12.10.1 Mirada Company Information
- 12.10.2 Mirada Business Overview
- 12.10.3 Mirada Revenue in Cancer Imaging Software Business (2021-2026)
- 12.10.4 Mirada Cancer Imaging Software Product Portfolio
- 12.10.5 Mirada Recent Developments
- 12.11 GE HealthCare
- 12.11.1 GE HealthCare Company Information
- 12.11.2 GE HealthCare Business Overview
- 12.11.3 GE HealthCare Revenue in Cancer Imaging Software Business (2021-2026)
- 12.11.4 GE HealthCare Cancer Imaging Software Product Portfolio
- 12.11.5 GE HealthCare Recent Developments
- 12.12 Mint Medical
- 12.12.1 Mint Medical Company Information
- 12.12.2 Mint Medical Business Overview
- 12.12.3 Mint Medical Revenue in Cancer Imaging Software Business (2021-2026)
- 12.12.4 Mint Medical Cancer Imaging Software Product Portfolio
- 12.12.5 Mint Medical Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst